The latest closing stock price for Gain Therapeutics as of November 21, 2024 is 1.62.
An investor who bought $1,000 worth of Gain Therapeutics stock at the IPO in 2021 would have $-855 today, roughly -1 times their original investment - a -38.33% compound annual growth rate over 4 years.
The all-time high Gain Therapeutics stock closing price was 15.80 on April 05, 2021.
The Gain Therapeutics 52-week high stock price is 5.33, which is 229% above the current share price.
The Gain Therapeutics 52-week low stock price is 0.89, which is 45.1% below the current share price.
The average Gain Therapeutics stock price for the last 52 weeks is 2.56.
An investor who bought $1,000 worth of Gain Therapeutics stock at the IPO in 2021 would have $-855 today, roughly -1 times their original investment - a -38.33% compound annual growth rate over 4 years.
The all-time high Gain Therapeutics stock closing price was 15.80 on April 05, 2021.
The Gain Therapeutics 52-week high stock price is 5.33, which is 229% above the current share price.
The Gain Therapeutics 52-week low stock price is 0.89, which is 45.1% below the current share price.
The average Gain Therapeutics stock price for the last 52 weeks is 2.56.